Press Releases

Press Releases

Core Faculty Members Lisa Prosser and James Hammitt recently published article is now available from Pharmacoeconomics:
Prosser LA, Hammitt JK, Keren R. Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations. Pharmacoeconomics. 2007;25(9):713-726.

A recent issue of HPV Today, featuring an interview with Dr. Sue Goldie is now available. You can download the PDF file by clicking on the link below.
Download HPV Today: www.hpvtoday.com/_english/_889downloads/HPVToday_09.pdf

Walensky et al. Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on Survival Journal of Infectious Diseases: Some 1.2 million deaths could be averted, over the next five years, by accelerating the rate of antiretroviral therapy (ART) scale up in South Africa, according to a study released today in the Journal of Infectious Diseases. Using a sophisticated mathematical model of HIV disease and treatment in South Africa, a team of researchers led by Dr. Rochelle Walensky of the Massachusetts GeneralHospital estimated the number of deaths through 2012 under alternative ART scale-up assumptions. Results show that maintaining current treatment capacity will lead to 2.4 million AIDS-related deaths by 2012. Accelerating the scale-up so that all eligible patients receive ART by 2011 will reduce the projected number of deaths to 1.2 million. The difference is explained by the disparity in one-year survival between eligible patients who receive antiretroviral therapy (94%) and those who do not (55%). The study underscores the urgent need for Congress to reauthorize the President’s Emergency Plan for AIDS Relief. “The loss of life associated with failure to provide ART to all who need it will be enormous,” says Walensky. “Deliberate, purposeful, and expedient scale-up will save millions of lives in South Africa alone.” The study was funded by the National Institute of Allergy and Infectious Diseases and the Doris Duke Charitable Foundation. Collaborating institutions included the Brigham and Women’s Hospital (Boston, MA), Harvard University (Boston, MA), the University of Cape Town (Cape Town, South Africa), Johns Hopkins University (Baltimore, MD), the Wits Health Consortium Perinatal HIV Research Unit (Johannesburg, South Africa), Boston University (Boston, MA), the Centre Hospitalier de Tourcoing, Faculté de Médecine de Lille, and Laboratoire de Recherches Économiques et Sociales (Lille, France), and Yale University (New Haven, CT).

Lisa Prosser, interviewed on WBUR radio about risk perception in the context of the flu vaccine. Click here to listen